Second vaccine sees investors eye recovery

Second vaccine sees investors eye recovery
Dan Brunskill
New Zealand shares edged higher as a second promising vaccine caused investors to shift money into mid-size companies that have been slower to recover from the pandemic. The S&P/NZX 50 Index rose 20.11 points, or 0.2 percent, to 12,765.03. Within the index, 29 stocks rose, 15 fell and six were unchanged. Turnover was $219.9 million.Offshore markets were buoyed by news about Moderna’s vaccine, which a 30,000-patient study showed to be 94 percent effective, it is also easier to distribute than Pfizer’s version.Only five patie...

More Markets

NZX down as property company gets key renewal
Markets Market Close

NZX down as property company gets key renewal

ASB Bank has extended the lease for its downtown Auckland site for another nine years.

Anna Scott joining Mercer
Markets

Anna Scott joining Mercer

Former Smart boss will replace current Mercer chief executive Martin Lewington.

Solar still on the rise, Ecotricity says
Markets

Solar still on the rise, Ecotricity says

Commercial solar generation is up almost 300%.

Expectations of rate cuts boost NZ sharemarket in light trade
Markets Market close

Expectations of rate cuts boost NZ sharemarket in light trade

There were 89 rises and 48 falls on the main board.

Jamie Gray 02 Jul 2025